Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis virus and kidney

K Praditpornsilpa1, S Eiam-Ong, V Sitprija

  • 1Department of Medicine, Faculty of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand.

Singapore Medical Journal
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Simple Novel Technique to Estimate Tacrolimus Dosages During the Early Post Kidney Transplantation Period.

Transplantation proceedings·2015
Same author

Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.

Transplantation proceedings·2015
Same author

The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Effects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients.

Transplantation proceedings·2014
Same author

Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.

British journal of pharmacology·2012
Same author

Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study.

Internal medicine journal·2012
Same journal

Response to comments on: Diagnostic classification of dermatomyositis with and without electrodiagnostic study: real-world clinical practice.

Singapore medical journal·2026
Same journal

Comments on: Diagnostic classification of dermatomyositis with and without electrodiagnostic study: real-world clinical practice.

Singapore medical journal·2026
Same journal

Computed tomographic evaluation of bronchiolitis: unravelling the multifaceted spectrum of airways and pulmonary abnormalities.

Singapore medical journal·2026
Same journal

Approach to facial pain.

Singapore medical journal·2026
Same journal

Glioblastoma: current challenges and future horizons.

Singapore medical journal·2026
Same journal

The role of public health specialists in tertiary hospitals in Singapore.

Singapore medical journal·2026
See all related articles

Hepatitis viruses A, B, and C can harm the kidneys, causing acute renal failure or glomerulonephritis. Their impact on kidney transplant recipients remains a complex issue.

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis A, B, and C viruses are primary causes of viral hepatitis.
  • These viruses can damage both liver and kidney tissues.
  • Kidney complications associated with viral hepatitis include acute renal failure and glomerulonephritis.

Purpose of the Study:

  • To review the impact of Hepatitis A, B, and C viruses on renal parenchyma.
  • To discuss the mechanisms of kidney damage caused by these viruses.
  • To explore the implications of viral hepatitis in kidney transplant recipients.

Main Methods:

  • Literature review of studies on viral hepatitis and kidney disease.
  • Analysis of evidence linking Hepatitis A, B, and C viruses to renal pathologies.

Related Experiment Videos

  • Examination of outcomes in post-renal transplant patients with viral hepatitis.

    • Main Results:

    • Hepatitis A virus can lead to acute renal failure, mimicking hepatorenal syndrome.
    • Chronic Hepatitis B virus infection is associated with immune complex glomerulopathy.
    • Hepatitis C virus is implicated in various forms of glomerulonephritis.
    • Hepatitis B and C viruses increase morbidity and mortality in kidney transplant patients.

    Conclusions:

    • Viral hepatitis poses significant risks to renal health.
    • The role of Hepatitis B and C viruses in kidney transplantation (donor or recipient) remains controversial.
    • Further research is needed to clarify management strategies for viral hepatitis in kidney transplant candidates and recipients.